Valuation (55%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 0.07 | N/A |
PEG Ratio (TTM) | N/A | N/A |
P/S Ratio (TTM) | 0.01 | N/A |
P/B Ratio (TTM) | -2,053.70 | N/A |
P/FCF Ratio (TTM) | 0.01 | N/A |
Price to 5YR AVG Earnings Ratio | -42.74 | N/A |
Price to 5YR AVG FCF Ratio | 13.63 | N/A |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.01% | N/A |
ROE (TTM) | -7,857.86% | N/A |
Net Profit Margin (TTM) | 19.52% | N/A |
ROIC 5YR AVG | -0.05% | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 23,777.33% | -117.73% | -33.31% |
Revenue | 24,939.72% | 2.60% | 5.18% |
Net Income | 23,990.91% | -116.71% | -32.49% |
Cash Flow | 78,749.84% | -14.75% | 0.90% |
Health (54%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 443.28 | N/A |
Quick Ratio (TTM) | 443.28 | N/A |
D/E Ratio (TTM) | -2,851.96 | N/A |
Interest Coverage (TTM) | 1,163.03 | N/A |
Piotroski F-Score | 8 | N/A |
Altman Z-Score | 0.07 | N/A |
LTL to 5YR AVG FCF | 23.88 | N/A |
Shares Outstanding Growth 5YR AVG | -0.77% | N/A |